BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27939475)

  • 1. Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1.
    Zsengellér ZK; Rajakumar A; Hunter JT; Salahuddin S; Rana S; Stillman IE; Ananth Karumanchi S
    Pregnancy Hypertens; 2016 Oct; 6(4):313-319. PubMed ID: 27939475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis.
    Covarrubias AE; Lecarpentier E; Lo A; Salahuddin S; Gray KJ; Karumanchi SA; Zsengellér ZK
    Am J Pathol; 2019 Jan; 189(1):104-114. PubMed ID: 30315766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling.
    Drewlo S; Levytska K; Sobel M; Baczyk D; Lye SJ; Kingdom JC
    J Thromb Haemost; 2011 Dec; 9(12):2486-97. PubMed ID: 21981655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy.
    Nadkarni NA; Rajakumar A; Mokhashi N; Burke SD; Rana S; Salahuddin S; Dang Q; Thadhani R; Krishnan R; Stossel TP; Karumanchi SA
    Pregnancy Hypertens; 2016 Oct; 6(4):333-339. PubMed ID: 27939478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia.
    Yonekura Collier AR; Zsengeller Z; Pernicone E; Salahuddin S; Khankin EV; Karumanchi SA
    Hypertens Pregnancy; 2019 Aug; 38(3):193-199. PubMed ID: 31291799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.
    Anton L; Merrill DC; Neves LA; Gruver C; Moorefield C; Brosnihan KB
    Reprod Biol Endocrinol; 2010 Nov; 8():135. PubMed ID: 21050477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
    Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Features of TLR4 Expression in Structural Elements of Placenta in Patients with Preeclampsia.
    Kulikova GV; Nizyaeva NV; Nagovitsina MN; Lyapin VM; Loginova NS; Kan NE; Tyutyunnik VL; Tyutyunnik NV; Schegolev AI
    Bull Exp Biol Med; 2016 Mar; 160(5):718-21. PubMed ID: 27021078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications.
    Fan X; Rai A; Kambham N; Sung JF; Singh N; Petitt M; Dhal S; Agrawal R; Sutton RE; Druzin ML; Gambhir SS; Ambati BK; Cross JC; Nayak NR
    J Clin Invest; 2014 Nov; 124(11):4941-52. PubMed ID: 25329693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of calcium transport channels in placenta primary cells and tissues derived from preeclamptic placenta.
    Yang H; Kim TH; An BS; Choi KC; Lee HH; Kim JM; Jeung EB
    Mol Cell Endocrinol; 2013 Mar; 367(1-2):21-30. PubMed ID: 23267838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells.
    Lin L; Li G; Zhang W; Wang YL; Yang H
    J Cell Physiol; 2019 Aug; 234(10):18928-18941. PubMed ID: 31004367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of angiogenic factors in the management of preeclampsia.
    Flint EJ; Cerdeira AS; Redman CW; Vatish M
    Acta Obstet Gynecol Scand; 2019 Jun; 98(6):700-707. PubMed ID: 30667052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence implicating peroxisome proliferator-activated receptor-γ in the pathogenesis of preeclampsia.
    McCarthy FP; Drewlo S; English FA; Kingdom J; Johns EJ; Kenny LC; Walsh SK
    Hypertension; 2011 Nov; 58(5):882-7. PubMed ID: 21931072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.